Company Profile

Beijing Kawin Technology Share-Holding Co., Ltd. (Kawin Technology) is located in the Beijing Economy-Technology Development Area (BDA), also well known as the "Pharmaceutical Valley". Based on biotechnology platforms, Kawin Technology is committed to becoming a public company that provides best healthcare solutions in Hepatology for our patients. Since establishment, Kawin Technology has formed strategic partnership with Legend Capital, Haitong Capital and Cybernaut respectively. Kawin Technology is a High & New Technology Enterprise certified by Beijing Municipal Science & Technology Commission. It has also been listed as Hundred Pilot Enterprises and Top 100 Most-promising Enterprises by Zhongguancun Technology Park (aka China's Silicon Valley).

Kawin Technology has a rapidly-growing R&D team, mainly composed of overseas returnee experts and local talents with doctor or master degrees. Among them, one was selected for China's prestigious national "Recruitment Program of Global Experts" and three were selected for the Beijing "High-end Leading Talents Program". Recognized as "Beijing Engineering Research Center for Recombinant Protein Drugs", our R&D center is striving to develop a series of new medicines through integrated innovation as well as collaborations from the national research projects such as the "11th Five-Year Plan" and "12th Five-Year Plan". We aim to establish a complete Hepatology product portfolio covering anti-virus, immunity-enhancing, liver protection, anti-fibrosis and anti-liver cancer.

Currently there are 19 ongoing R&D projects in our R&D center, including 6 biological products, 7 chemical products and 6 technology platforms. We have filed more than 50 patent applications, 18 of which were granted so far.

"Innovation for a better life"! Kawin Technology is becoming a leading pharmaceutical brand in hepatology, making every effort to improve the wellbeing of human beings.